禽流感A(H5N1)
Avian influenza A(H5N1) is a flu virus that mainly infects birds, but it can sometimes infect people. The human cases reported to the World Health Organization have usually followed close contact with sick or dead birds, some infected mammals, or contaminated environments. WHO said that from 2003 to 2025 almost all reported human cases had this kind of exposure, and that sustained spread from person to person has not been documented in the recent notices retrieved here. Illness in people can range from mild infection or even no symptoms to severe pneumonia and death. In WHO’s global count, 986 human cases and 473 deaths were reported from 25 countries by 2025-07-01, which is a reported case fatality ratio of 48%, though this reflects detected cases and can change over time. Antiviral drugs such as oseltamivir and zanamivir may help, especially when started early. The sources retrieved here do not establish a widely used human vaccine for the general public, so vaccine status is listed as unknown.
关键事实
| 传播 | 通常为人畜共患病:与感染的活鸟或死鸟、某些感染的哺乳动物或受污染环境密切接触;在检索到的世卫组织报告中未确立持续的人传人传播。 |
|---|---|
| 潜伏期 | 未知 |
| 病死率 | 48% among 986 WHO-reported human cases worldwide from 2003 to 2025-07-01 (473 deaths); country figures vary, for example Cambodia reported 59% cumulatively since 2003 and 44% for cases reported after re-emergence in 2023-2025. |
| 再生数 | 未知 |
| 疫苗 | 从检索到的资料中未知;所审查的文件中未建立广泛使用的公众人用疫苗。 |
| 治疗 | 支持性治疗加抗病毒药物可能有帮助;世卫组织指出,神经氨酸酶抑制剂如奥司他韦和扎那米韦已被证明可缩短病毒复制时间并改善部分病例的预后,应在症状出现48小时内使用。 |
| 宿主 | 野鸟和家禽是主要宿主;世卫组织还指出某些哺乳动物中有病毒循环。 |
| 流行地区 | Virus circulation in animals is global in wild birds, poultry, and some mammals; human infections reported to WHO came from 25 countries by 2025-07-01. |
传播途径
H5N1主要是动物感染,而非常规人类感染。在此处检索到的世卫组织通报中,几乎所有人类病例均与接触感染的活鸟或死鸟、感染的哺乳动物或受其污染的环境有关。柬埔寨2025年报告称,当年所有11例病例均处理或扑杀了病禽,通常是家禽。世卫组织对柬埔寨、墨西哥、越南和美国近期病例的评估均显示相同的总体模式:人们通常暴露于感染动物或受污染环境中,随访中未发现其他相关人类病例。这并不意味着人传人传播不可能,但检索到的世卫组织报告中未记录持续的人传人传播。这一点很重要,因为如果病毒发生易于人传人的变化,将极大改变公共卫生风险。
- Avian Influenza A(H5N1) - Cambodia WHO · 2025年7月5日
- Avian Influenza A(H5N1) - Mexico WHO · 2025年4月17日
- Avian Influenza A(H5N1) – United States of America WHO · 2024年4月9日
- Avian Influenza A(H5N1) – Viet Nam WHO · 2024年4月2日
症状和严重程度
Illness from H5N1 in people can look very different from one case to another. WHO’s Cambodia report says human infection may range from mild upper respiratory symptoms to severe, life-threatening disease. Reported features include conjunctivitis, breathing symptoms, stomach or bowel symptoms, encephalitis, and encephalopathy. Some infected people have had no symptoms at all and were found only because they were tested after exposure. Even so, the disease can be very serious. WHO reported 986 human cases and 473 deaths worldwide from 2003 to 2025-07-01, a reported case fatality ratio of 48%. Recent country reports also show that severity varies: Cambodia reported 49 deaths among 83 cumulative cases since 2003, while its re-emergence period from 2023 to 2025 had 12 deaths among 27 cases. These figures describe detected and reported cases, not necessarily every infection.
- Avian Influenza A(H5N1) - Cambodia WHO · 2025年7月5日
- Avian Influenza A(H5N1)- Cambodia WHO · 2024年9月2日
- Avian Influenza A(H5N1) – United States of America WHO · 2024年4月9日
治疗和疫苗
检索资料中最明确的治疗信息是关于抗病毒药物。世卫组织称,神经氨酸酶抑制剂,尤其是奥司他韦和扎那米韦,已被证明可缩短病毒复制时间,并可能改善部分病例的预后。世卫组织还指出,这些药物应在症状出现48小时内开始使用。重症患者可能还需要住院治疗和呼吸支持,但检索到的世卫组织资料未提供完整的治疗方案。关于疫苗,本节收集的资料未确定广泛可用的公众人用H5N1疫苗,因此疫苗状态列为未知,而非猜测。这种不确定性不应被解读为疫苗研究不存在;仅表示本页面检索的文件未提供足够直接细节以明确公众疫苗推荐。
- Avian Influenza A(H5N1) - Cambodia WHO · 2025年7月5日
- Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Europe PMC · 2019年3月1日
分布地区
H5N1 circulates widely in animals. WHO says the virus is present in wild birds, poultry, and some mammals around the world, so occasional human infections are expected where people have close exposure. By 2025-07-01, WHO had recorded 986 human cases from 25 countries. The recent WHO notices retrieved here show how scattered these events can be: Cambodia has reported repeated human cases; Viet Nam reported a fatal case in 2024; the United States reported a human infection linked to dairy cattle in 2024; Australia reported its first human H5N1 infection in 2024, likely acquired during travel; and Mexico reported its first confirmed human H5N1 infection in 2025. So this is not a disease confined to one country. The main pattern is global circulation in animals with uncommon, usually exposure-related human spillover.
- Avian Influenza A(H5N1) - Cambodia WHO · 2025年7月5日
- Avian Influenza A(H5N1) - Mexico WHO · 2025年4月17日
- Avian Influenza A (H5N1) - Australia WHO · 2024年6月7日
- Avian Influenza A(H5N1) – United States of America WHO · 2024年4月9日
近期历史
This site’s archive lists 71 past H5N1-related events, showing that the virus has appeared in public-health notices many times since the late 1990s. The recent pattern in the WHO material is still mostly sporadic human infection after animal exposure, but there are important changes in where those exposures are happening. Cambodia reported renewed human activity after several quiet years, with 6 cases in 2023, 10 in 2024, and 11 by 2025-07-01. In 2024, the United States reported a human case after exposure to infected dairy cattle, which WHO described as the first known human H5N1 infection acquired from contact with an infected mammal of that kind. Australia reported its first human H5N1 infection in 2024, and Mexico its first confirmed human H5N1 infection in 2025. WHO’s risk assessment in the retrieved notices remained low for the general population, while higher for people with occupational exposure.
- Avian Influenza A(H5N1) - Cambodia WHO · 2025年7月5日
- Avian Influenza A(H5N1) - Mexico WHO · 2025年4月17日
- Avian Influenza A (H5N1) - Australia WHO · 2024年6月7日
- Avian Influenza A(H5N1) – United States of America WHO · 2024年4月9日
关注重点
最大的警示信号将是有证据表明H5N1在人与人之间高效传播,尤其是如果接触者追踪开始发现无直接动物暴露的感染链。另一个重要信号是病毒传播到新的动物宿主或新的地区,增加人类接触,如美国的乳牛和波兰的猫等异常哺乳动物事件。公共卫生团队还应关注抗病毒药物耐药性,因为世卫组织当前的治疗建议依赖奥司他韦和扎那米韦等药物。疾病严重程度的变化也很重要:更严重的病情、更多死亡或更多在医疗或家庭环境中的感染都会引起关注。最后,如果为高风险群体提供疫苗,则供应和与流行株的匹配将很重要。根据此处检索的世卫组织通报,目前普通公众风险仍然较低,但情况需持续监测,因为流感病毒会随时间变化。
- Avian Influenza A(H5N1) - Cambodia WHO · 2025年7月5日
- Avian Influenza A(H5N1) – United States of America WHO · 2024年4月9日
- Influenza A(H5N1) in cats – Poland WHO · 2023年7月16日
- Avian Influenza A(H5N1) - Mexico WHO · 2025年4月17日
相关疫情
- 禽流感H5N1 关注度: 高